Pulmonary Vein Ablation Versus Amiodarone in the Elderly

Inclusion Criteria: * Age ≥ 65 years at moment of screening, able to sign informed consent. * Documented paroxysmal AF in association with complaints in the last year, with at least 2 episodes of complaints attributed to AF in the previous 2 months. * Paroxysmal AF documented with at least one ECG with sinus rhythm not after cardioversion in the last year. * No prior use of amiodarone in the last 6 months and no usage longer than 4 weeks in total. Exclusion Criteria: * EF \< 35 % or description of "poor left ventricular function" on echocardiogram. Measurement should not be older than 6 months at moment of screening. * Aortic, mitral, pulmonary or tricuspid valve regurgitation or stenosis, if graded severe (grade \>3) * Acute illness: unstable angina, infectious disease. * Primary structural or electrical heart disease: dilated cardiomyopathy, hypertrophic cardiomyopathy, Brugada syndrome, long QT syndrome. * Reversible causes (thyroid dysfunction, uncontrolled hypertension, ischemia). * Previous ablation. * Contraindications for amiodarone; liver dysfunction (serum alanine aminotransferase \>2.5 times upper limit); thyroid dysfunction; chronic lung disease; baseline QTc \>460 ms. sinus node dysfunction (pause more than 3 seconds in sinus rhythm); second or third degree AV-block. * Contraindications for anti-coagulation: prior life threatening hemorrhage under use of Vitamin K antagonists. * Any myocardial infarction or PCI in previous 6 months. * CABG in previous 6 months. * Renal dysfunction: creatinine clearance \<45 ml/min * Severe co-morbidity. Life expectancy less than 1 year. * Thrombus in left atrium * Untreatable allergy to contrast media